… plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… epidermal growth factor receptor (EGFR) signal transduction pathway, and to improve the
anti-tumor … (3) Gefitinib and erlotinib are the first small molecule tyrosine kinase inhibitors (TKIs…
anti-tumor … (3) Gefitinib and erlotinib are the first small molecule tyrosine kinase inhibitors (TKIs…
[HTML][HTML] Erosive pustular dermatosis of the scalp following cetuximab 使用西妥昔單抗後, 出現糜爛膿皰性頭皮皮膚病一例
P Peters, C Bissex, J Gajra, N Gorddard, D Rubel - medcomhk.com
… inhibits the epidermal growth factor receptor and thus inhibits cell proliferation, angiogenesis
and potential … from the use of epidermal growth factor receptor inhibitors, with a positive …
and potential … from the use of epidermal growth factor receptor inhibitors, with a positive …
靈芝三萜T-612 透過誘導細胞自噬以促進Sorafenib 於肝癌細胞株之效能
蔡黛華 - 2012 - tdr.lib.ntu.edu.tw
… restored by autophagy inhibitor 3-MA. In conclusion, T-612 is a potential anti-cancer adjuvant
that … resistance-associated tumour suppressor gene Vascular endothelial growth factor …
that … resistance-associated tumour suppressor gene Vascular endothelial growth factor …
[PDF][PDF] 晚期非小细胞肺癌的二线治疗进展
张力 - 2008 - scholar.archive.org
… drugs in the 2nd line were docetaxel, pemetrexed and epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR… Development of the novel biologically targeted anticancer agent …
kinase inhibitors (EGFR… Development of the novel biologically targeted anticancer agent …
非小细胞肺癌患者T790M 突变致酪氨酸激酶的耐药机制及用药策略
夏媛媛， 张国庆， 胡毅 - 解放军医学院学报, 2016 - xuebao.301hospital.com.cn
… 酪氨酸激酶抑制剂(epidermal growth factor receptor-tyrosine kinase inhibitor,EGFR-TKI)
治疗… EGFR-TKI resistance caused by T790M mutation update constantly. In this review, we …
治疗… EGFR-TKI resistance caused by T790M mutation update constantly. In this review, we …
[HTML][HTML] 非小细胞肺癌小分子的靶向治疗研究进展
申越， 王睿， 高婧， 尹楠， 王文杰… - World Journal of Cancer …, 2022 - hanspub.org
… to the rapid development of various molecular targeted drugs. Molecular targeted drugs
such as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR- TKI) block important …
such as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR- TKI) block important …
[HTML][HTML] Recent progress of research on herbal products used in traditional Chinese medicine: the herbs belonging to the divine Husbandman's herbal foundation …
KH Lee, S Morris-Natschke, K Qian, Y Dong… - Journal of Traditional …, 2012 - Elsevier
… cell invasion and metastasis, inhibit angiogenesis, down-regulate epidermal growth factor
receptors, and inhibit signal transducers and activators of transcription 3 (Stat 3) (Liu et al., …
receptors, and inhibit signal transducers and activators of transcription 3 (Stat 3) (Liu et al., …
[HTML][HTML] HER2 阳性非小细胞肺癌诊断及治疗进展
REN Chenyi, CAO He, Z Jing… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
… HER2阳性也被认为是表皮生长因子受体（epidermal growth factor receptor, EGFR）-TKIs获得
性耐药的可能机制 [5] 。HER2突变发生在2%-4% NSCLC患者中，其中以TKD内的外显子20插入…
性耐药的可能机制 [5] 。HER2突变发生在2%-4% NSCLC患者中，其中以TKD内的外显子20插入…
[HTML][HTML] 浸润性乳腺癌组织HER2 与Ki67 联合表达与蒽环类化疗药物的疗效及预后相关
赵伟志， 赵薇， 杨小兵， 赵坤 - 南京医科大学学报(自然科学版), 2021 - jnmu.njmu.edu.cn
… 人类表皮生长因子受体2(human epidermal growth factor receptor⁃2,HER2),为表皮生长因子受体
家族成员之一.HER2高表达的肿瘤表现出较强的转移能力和浸润能力,化疗敏感性也较低 [4-5…
家族成员之一.HER2高表达的肿瘤表现出较强的转移能力和浸润能力,化疗敏感性也较低 [4-5…
[HTML][HTML] 中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（ 2020 年版）
周彩存， 王洁， 王宝成， 程颖， 王哲海… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
… ICIs have become the standard treatment for advanced NSCLC without epidermal growth
factor receptor(EGFR) mutation or anaplastic lymphomakinase(ALK) translocation in the first- …
factor receptor(EGFR) mutation or anaplastic lymphomakinase(ALK) translocation in the first- …